![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 4
Zeitschriftenartikel
Zhang, Danmei 
ORCID: https://orcid.org/0000-0001-6048-4711; Westphalen, Christoph Benedikt; Quante, Michael; Waldschmidt, Dirk T.; Held, Swantje ORCID: https://orcid.org/0000-0002-1344-9056; Kütting, Fabian; Dorman, Klara; Heinrich, Kathrin ORCID: https://orcid.org/0000-0003-3580-2313; Weiss, Lena; Boukovala, Myrto; Haas, Michael; Boeck, Stefan; Heinemann, Volker ORCID: https://orcid.org/0000-0002-1349-3321 und Probst, Victoria
(2024):
Gemcitabine and nab-paclitaxel combined with afatinib in metastatic pancreatic cancer. Results of a phase 1b clinical trial.
In: European Journal of Cancer, Bd. 201, 113926
[PDF, 1MB]
ORCID: https://orcid.org/0000-0001-6048-4711; Westphalen, Christoph Benedikt; Quante, Michael; Waldschmidt, Dirk T.; Held, Swantje ORCID: https://orcid.org/0000-0002-1344-9056; Kütting, Fabian; Dorman, Klara; Heinrich, Kathrin ORCID: https://orcid.org/0000-0003-3580-2313; Weiss, Lena; Boukovala, Myrto; Haas, Michael; Boeck, Stefan; Heinemann, Volker ORCID: https://orcid.org/0000-0002-1349-3321 und Probst, Victoria
(2024):
Gemcitabine and nab-paclitaxel combined with afatinib in metastatic pancreatic cancer. Results of a phase 1b clinical trial.
In: European Journal of Cancer, Bd. 201, 113926
[PDF, 1MB]
Weiss, Lena; Heinemann, Volker ORCID: https://orcid.org/0000-0002-1349-3321; Fischer, Laura E.; Gieseler, Frank; Hoehler, Thomas; Mayerle, Julia ORCID: https://orcid.org/0000-0002-3666-6459; Quietzsch, Detlef; Reinacher-Schick, Anke; Schenk, Michael; Seipelt, Gernot; Siveke, Jens T.; Stahl, Michael; Vehling-Kaiser, Ursula; Waldschmidt, Dirk T.; Dorman, Klara; Zhang, Danmei; Westphalen, C. Benedikt ORCID: https://orcid.org/0000-0002-5310-3754; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X; Boeck, Stefan und Haas, Michael ORCID: https://orcid.org/0000-0001-6745-7177
(2023):
Three-month life expectancy as inclusion criterion for clinical trials in advanced pancreatic cancer: is it really a valid tool for patient selection?
In: Clinical and Translational Oncology, Bd. 26, Nr. 5: S. 1268-1272
[PDF, 430kB]
ORCID: https://orcid.org/0000-0002-1349-3321; Fischer, Laura E.; Gieseler, Frank; Hoehler, Thomas; Mayerle, Julia ORCID: https://orcid.org/0000-0002-3666-6459; Quietzsch, Detlef; Reinacher-Schick, Anke; Schenk, Michael; Seipelt, Gernot; Siveke, Jens T.; Stahl, Michael; Vehling-Kaiser, Ursula; Waldschmidt, Dirk T.; Dorman, Klara; Zhang, Danmei; Westphalen, C. Benedikt ORCID: https://orcid.org/0000-0002-5310-3754; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X; Boeck, Stefan und Haas, Michael ORCID: https://orcid.org/0000-0001-6745-7177
(2023):
Three-month life expectancy as inclusion criterion for clinical trials in advanced pancreatic cancer: is it really a valid tool for patient selection?
In: Clinical and Translational Oncology, Bd. 26, Nr. 5: S. 1268-1272
[PDF, 430kB]
Striefler, Jana K.; Reissig, Timm M.; Kunzmann, Volker; Westphalen, C. Benedikt; Boeck, Stefan; Ettrich, Thomas J.; Lutz, Manfred P.; Waldschmidt, Dirk T.; Brunner, Thomas; Uhl, Waldemar; Sinn, Marianne und Siveke, Jens T.
(2022):
Das Pankreaskarzinom. Klinische Projekte der onkologischen Studiengruppen in Deutschland (ACO, AIO und ARO).
In: Onkologe, Bd. 28, Nr. SUPPL 1: S. 30-35
Westphalen, C. Benedikt; Kukiolka, Tobias; Garlipp, Benjamin; Hahn, Lars; Fuchs, Martin; Malfertheiner, Peter; Reiser, Marcel; Kuetting, Fabian; Heinemann, Volker; Beringer, Andreas und Waldschmidt, Dirk T.
(2020):
Correlation of skin rash and overall survival in patients with pancreatic cancer treated with gemcitabine and erlotinib - results from a non-interventional multi-center study.
In: BMC Cancer, Bd. 20, Nr. 1